Skip to main content
Open Forum Infectious Diseases logoLink to Open Forum Infectious Diseases
. 2026 Apr 2;13(4):ofag191. doi: 10.1093/ofid/ofag191

Klebsiella Pneumoniae Liver Abscess as the Herald of Underlying Colorectal Neoplasm

Tsen-En Liao 1,2, Chien Chuang 3,4,, Szu-Yu Liu 5,6, Yu-Chien Ho 7,8,9, Wan Chin 10, Sheng-Hua Chou 11,12, Yi-Tsung Lin 13,14,15,✉,2
PMCID: PMC13075939  PMID: 41983149

Abstract

Background

Klebsiella pneumoniae liver abscesses (KPLA) remain endemic to Taiwan. Hypervirulent strains in the gut can translocate across colonic mucosal defects into the portal circulation, causing subsequent liver abscesses. Occult colorectal cancer in patients with KPLA has been reported in a case series. Herein, we determined whether the diagnosis of KPLA serves as a harbinger of colorectal neoplasms.

Methods

Consecutive patients with KPLA treated at Taipei Veterans General Hospital in Taiwan between April 2011 and January 2024 were retrospectively enrolled. Hypervirulent K. pneumoniae strains were defined as those harboring mutations in rmpA or rmpA2. Patients who underwent colonoscopy within 6 months of diagnosis were included in the analysis. Logistic regression was used to assess the risk factors for colorectal adenomas and adenocarcinomas.

Results

A total of 489 patients with KPLA were identified during the study period, of which 114 (23.3%) underwent colonoscopy within 6 months of the diagnosis of KPLA. Most K. pneumoniae strains were hypervirulent (95.1%). Colonoscopy findings showed 48 (42.1%) cases of adenomas and 13 (11.4%) of adenocarcinomas. Age ≥ 50 years was the only independent factor for colorectal adenoma/adenocarcinoma (odds ratio = 5.728, 95% CI = 2.045–16.04, P = .001). During follow-up, most patients with adenocarcinoma (11/13, 84.6%) remained disease-free post-surgery. Of the 48 patients with adenomas, 2 developed colorectal cancer.

Conclusions

Colorectal adenomas and adenocarcinomas are common in patients with KPLA. Colonoscopy should be routinely performed in patients with KPLA, particularly those aged ≥ 50 years.

Keywords: colon cancer, Klebsiella pneumoniae, liver abscess


Upon diagnosis of Klebsiella pneumoniae liver abscess (KPLA), >50% of the patients had occult colorectal cancer or adenoma. Age ≥ 50 was the only independent risk factor. Our findings support the routine use of colonoscopy for patients with KPLA.


Pyogenic liver abscess (PLA) is a common disease in Taiwan, with an annual incidence that increased from 10.83 to 15.45 per 100 000 person-years between 2000 and 2011 [1]. In contrast to that in Western countries, Klebsiella pneumoniae is the most common cause of liver abscesses in Taiwan and other Asian countries [2]. K. pneumoniae liver abscess (KPLA) is an endemic disease in Taiwan, usually attributed to hypervirulent strains [3]. Hypervirulent K. pneumoniae strains, most of which belong to serotype K1/K2, can cause pyogenic infections, even in healthy individuals. Metastatic infections, such as meningitis and endophthalmitis, are often associated with KPLA, leading to severe complications [4].

Klebsiella pneumoniae liver abscess originates from K. pneumoniae colonizing the patient's own gastrointestinal tract [5], and hypervirulent strains may cross the compromised intestinal barrier, spread via portal circulation, and subsequently disseminate to the liver through hematogenous routes [6]. Our previous study has shown that the fecal carriage rate of hypervirulent K. pneumoniae (serotypes K1/K2) in healthy adults was 11.3% [7]. Another study from Korea reported a carriage rate of serotype K1 K. pneumoniae in stool samples from healthy adults of 21.1% [8]. The mechanisms underlying the interaction between K. pneumoniae and the host intestinal epithelium, as well as bacterial translocation, remain unclear.

Colorectal cancer is the most common malignancy and second most deadly cancer [9]. Most cancers originate from precancerous lesions or adenomatous polyps [10]. Colorectal neoplasms can compromise the mucosal barrier, creating a pathway for bacterial invasion of the portal venous system or systemic circulation, which can lead to liver abscess formation [6, 11, 12]. Studies from Korea conducted 20 years ago demonstrated that the rate of a hidden colorectal cancer in liver abscesses ranged from 7.4% to 16.2%; however, the number of patients undergoing colonoscopy was limited [12, 13].

In Taiwan, the endemic nature of KPLA presents a unique opportunity to study its association with underlying colorectal neoplasm. Therefore, in this study, we investigated whether the diagnosis of KPLA serves as a marker for occult colorectal neoplasms in Taiwan in the current era.

METHODS

Study Design

This retrospective study included adult hospitalized patients diagnosed with KPLA between January 2011 and January 2024 at Taipei Veterans General Hospital, a tertiary referral center with 3000 beds in Taipei, Taiwan. We excluded patients aged < 20 years and those diagnosed with colorectal cancer prior to KPLA. Data on age, sex, underlying diseases, imaging results (including abscess location, abscess size, gas formation, multiple liver abscesses, metastatic lesions, and concurrent bacteremia), day of hospitalization, treatment, and outcomes were collected from electronic medical charts. For the colonoscopy results, we only included data from colonoscopies performed within six months of KPLA diagnosis. The diagnosis of adenoma or adenocarcinoma based on colonoscopy was based on the pathological reports. Ethical approval for this study was granted by the Institutional Review Board of Taipei Veterans General Hospital, and the requirement for informed consent was waived because of the retrospective nature of the study.

Data Collection and Definitions

Klebsiella pneumoniae liver abscess was defined as the presence of ≥ 1 liver abscess(es) detected via ultrasonography or computed tomography and culture-confirmed K. pneumoniae isolated from an abscess or blood [14]. Multiple liver abscesses were defined as ≥ 3 abscesses in the liver parenchyma confirmed by imaging [14]. Metastatic infection was designated as a distant site of infection isolated with K. pneumoniae. Multidrug resistance was defined as K. pneumoniae isolate with non-susceptibility to at least one agent in ≥ 3 antimicrobial categories [15]. If the origin of the liver abscess was associated with the clinical features of cholecystitis/cholangitis or if extrahepatic biliary duct abnormalities were found on radiographic images, it was classified as having a biliary tract origin. The remaining liver abscesses were classified as cryptogenic in origin [14].

Microbiological Methods

Bacterial species were identified using a VITEKⓇ2 system (bioMérieux, Marcy-l’Étoile, France) or matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF/MS) (bioMérieux). Capsular types of K. pneumoniae isolates were determined using polymerase chain reaction (PCR) to detect K serotype-specific alleles at the Wzy loci for the K1, K2, K5, K20, K54, and K57 types. Hypervirulent strains were defined as those with rmpA/rmpA2 genes [16].

Statistical Analysis

Continuous data are expressed as the mean ± standard deviation or the median (interquartile range [IQR]), depending on whether they are normally distributed. Chi-square and Fisher's exact tests were used to compare categorical data. Comparisons between groups were performed using the paired-sample t-test or Mann–Whitney U test, depending on whether the data were normally distributed. All variables with a P-value < .1 in the univariate analysis were included in the multivariate logistic regression model. Odds ratios (OR) with 95% CIs were calculated, and a P-value < .05 was considered statistically significant. Statistical analyses were performed using IBM SPSS Statistics (version 24.0; IBM Corp., Armonk, NY, USA).

RESULTS

Clinical Features of All Patients With KPLA

During the study period, 489 patients with KPLA met the inclusion criteria; among them, 114 underwent colonoscopy within 6 months of KPLA diagnosis. The clinical characteristics of 489 patients with KPLA are listed in Table 1. The mean age of the patients was 64.0 years, and 317 (64.8%) were males. Type 2 diabetes mellitus was the most common underlying condition, affecting 231 patients (47.2%). Most liver abscesses were cryptogenic (425/489, 86.9%) and predominantly located in the right lobe of the liver (343/489, 70.1%), with a median size of 5.5 cm (IQR 3.9–7.5). Gas-forming abscesses were observed in 42 patients (8.6%), while 81 (16.6%) had multiple abscesses, and 29 (5.9%) presented with metastatic infections. Approximately one-fifth of patients (n = 104, 21.3%) required admission to the intensive care unit. Nearly 90% of the patients underwent percutaneous drainage of the abscess as source control. Only 3 patients (0.6%) died during hospitalization.

Table 1.

Clinical Characteristics of Patients With KPLA Who Underwent Colonoscopy

Characteristics Total
n = 489
Colonoscopy
n = 114 (23.3)
No Colonoscopy
n = 375 (76.7)
P Value
Male, n (%) 317 (64.8) 73 (64) 244 (65.1) .84
Age, years (medium IQR) 64 (54–75.5) 60.5 (50.8–69) 65 (55–77) .001
Age ≥50 years 405 (82.8) 88 (77.2) 317 (84.5) .069
Body mass index, kg/m2 (medium IQR) 25.1 (22.7–27.4) 25.3 (22.6–28) 25.1 (22.8–27.3) .553
Obesity (body mass index ≥24) 285 (61.8) 71 (65.7) 214 (60.6) .338
Comorbidity, n (%)
 Diabetes mellitus 231 (47.2) 44 (38.6) 187 (49.9) .035
 Cancer 50 (10.2) 8 (7) 42 (11.2) .197
 Liver cirrhosis 7 (1.4) 1 (0.9) 6 (11.2) .487
 Congestive heart failure 28 (5.7) 4 (3.5) 24 (6.4) .245
 Chronic obstructive pulmonary disease 12 (2.5) 2 (1.8) 10 (2.7) .443
 Chronic kidney disease (eGFR < 60) 34 (7) 8 (7) 26 (6.9) .975
 Cerebrovascular accident 32 (6.5) 1 (0.9) 31 (8.3) .005
 Autoimmune disease 8 (1.6) 0 8 (2.1) .118
Origin of K. pneumoniae liver abscessa
 Cryptogenic 425 (86.9) 105 (92.1) 320 (85.3) .06
 Biliary 64 (13.1) 9 (7.9) 55 (14.7) .06
Abscess locationb
 Right lobes 343 (70.1) 82 (71.9) 261 (69.9) .634
 Left lobes 89 (18.2) 22 (19.3) 67 (17.9) .729
 Both lobes 56 (11.5) 9 (7.9) 47 (12.5) .173
Abscess size (medium IQR) 5.5 (3.9–7.5) 5.1 (3.5–7.3) 5.7 (4–7.6) .123
Abscess size > 5 cm 280 (57.3) 59 (51.8) 221 (58.9) .175
Gas forming 42 (8.6) 6 (5.3) 36 (9.6) .148
Multiple liver abscessc 81 (16.6) 11 (9.6) 70 (18.7) .023
Metastatic lesion 29 (5.9) 6 (5.3) 23 (6.1) .73
Bacteremia 228 (46.6) 55 (48.2) 173 (46.1) .692
Hospital days (medium IQR) 22 (15–31) 17 (10–28.3) 23 (16–32) <.001
Intensive care unit admission 104 (21.3) 19 (16.7) 85 (22.7) .170
Mortality in hospital 3 (0.6) 0 3 (0.8) .450
Treatment
 Antibiotic and drainage 422 (86.3) 98 (86) 324 (86.4) .906
 Antibiotic and operation 8 (1.6) 1 (0.9) 7 (1.9) .409
 Only antibiotic 62 (12.7) 15 (13.2) 47 (12.5) .861
Microbiological characteristics of K. pneumoniae isolates
rmpA or rmpA2 positive 405/426 (95.1) 106 (98.1) 299 (94) .087
Capsular type (with rmpA n  =  426)
 K1 and K2 315 (73.9) 75 (69.4) 240 (75.5) .333
 K1 238 (56.3) 62 (57.9) 176 (55.7) .685
 K2 77 (18.2) 14 (13.1) 63 (19.9) .112
 K5 24 (5.7) 7 (6.5) 17 (5.4) .653
 K20 9 (2.1) 4 (3.7) 5 (1.6) .239
 K54 13 (3.1) 3 (2.8) 10 (3.2) .574
 K57 12 (2.8) 6 (5.6) 6 (1.9) .083
 K1, K2, K5, K20, K54, and K57 373 (88.2) 96 (89.7) 277 (87.7) .568
Any drug resistance 23 (4.7) 3 (2.6) 20 (5.3) .233
Multidrug resistance 16 (3.3) 0 16 (4.3) .013

Data are presented as n (%) of patients unless stated otherwise.

aCryptogenic KPLA was defined as those cases without obvious extrahepatic source of infection; biliary KPLA was defined when the clinical features of cholecystitis/cholangitis or extrahepatic biliary. Ductal abnormalities were identified by image studies.

bOne patient underwent colonoscopy, revealing an abscess located in the caudate lobe.

cDefined as >2 abscesses on imaging.

A total of 426 K. pneumoniae isolates (426/489, 87.1%) were available for microbiological analysis; most of them (405/426, 95.1%) were hypervirulent strains. Capsular types K1, K2, K5, K20, K54, and K57 accounted for 88.2% (373/426) of hypervirulent K. pneumoniae strains. K1 was the most common capsular type (238/426, 56.3%), followed by K2 (77/426, 18.2%), K5 (24/426, 5.7%), K54 (13/426, 3.1%), K57 (12/426, 2.8%), and K20 (9/426, 2.1%).

The clinical characteristics of patients who underwent colonoscopy (n = 114) were similar to those who did not (n = 375), except for younger age, a lower proportion of underlying cerebrovascular accidents, diabetes, multiple liver abscesses, and multiple-drug resistant strains, and shorter hospital stay in patients who underwent colonoscopy (Table 1).

Comparison of Clinical Characteristics of Patients With KPLA With or Without Colorectal Adenoma or Adenocarcinoma

Among 114 patients with KPLA who have undergone colonoscopy within 6 months of diagnosis, as high as 72 (63.2%) had colorectal polyps and/or cancer and underwent polypectomies for polyps or cancer biopsies. Pathological findings revealed adenoma in 48 patients and adenocarcinoma in 13 patients. The remaining 11 had hyperplastic polyps (n = 8), inflammatory polyps (n = 2), or sessile serrated lesions (n = 1). We compared the clinical characteristics of the patients with and without adenoma/adenocarcinoma (Table 2). Patients with adenomas or adenocarcinomas were older (65, IQR = 56–74.5 vs 55, IQR = 43.5–66, P < .001) and had a higher proportion of males (73.6% vs 55.7%, P = .048) compared to those without.

Table 2.

Comparison of Clinical Characteristics of Patients With KPLA With or Without Colorectal Adenoma or Adenocarcinoma

Characteristics Total
n = 114
Adenoma Or Adenocarcinoma
n = 61 (53.5)
Not Adenoma/adenocarcinoma
n = 53 (46.5)
P Value
Male, n (%) 73 (64) 34 (55.7) 39 (73.6) .048
Age, years (medium IQR) 60.5 (15.8–69) 65 (56–74.5) 55 (43.5–66) <.001
Age ≥50 years 88 (77.2) 55 (90.2) 33 (62.3) <.001
Body mass index, kg/m2 (medium IQR) 25.3 (22.6–28) 25.4 (22.6–27.8) 25.1 (22.5–28.4) .702
Obesity (body mass index ≥24) 71 (65.7) 39 (66.1) 32 (65.3) .931
Comorbidity, n (%)
 Diabetes mellitus 44 (38.6) 26 (42.6) 18 (34) .343
 Cancer 8 (7) 5 (8.2) 3 (5.7) .722
 Liver cirrhosis 1 (.9) 1 (1.6) 0 1.000
 Congestive heart failure 4 (3.5) 2 (3.3) 2 (3.8) 1.000
 Chronic obstructive pulmonary disease 2 (1.8) 2 (3.3) 0 .498
 Chronic kidney disease (eGFR < 60) 8 (7) 5 (8.2) 3 (5.7) .722
 Cerebrovascular accident 1 (0.9) 1 (1.6) 0 1.000
Origin of K. pneumoniae liver abscessa
Cryptogenic 105 (92.1) 57 (93.4) 48 (90.6) .731
Biliary 9 (7.9) 4 (6.6) 5 (9.4) .731
Abscess locationb
 Right lobes 82 (71.9) 40 (65.6) 42 (79.2) .105
 Left lobes 22 (19.3) 14 (23) 8 (15.1) .289
 Both lobes 9 (7.9) 6 (9.8) 3 (5.7) .5
Abscess size (medium IQR) 5.1 (3.5–7.3) 5 (3.5–7.5) 5.2 (3.5–6.7) .517
Abscess size > 5 cm 59 (51.8) 30 (49.2) 29 (54.7) .555
Gas forming 6 (5.3) 3 (4.9) 3 (5.7) 1.000
Multiple liver abscessc 12 (10.5) 5 (8.2) 7 (13.2) .385
Metastatic lesion 6 (5.3) 3 (4.9) 3 (5.7) 1.000
Bacteremia 54 (47.4) 27 (44.3) 27 (50.9) .476
Length of stay (medium IQR) 17 (10–28.3) 19 (13–31.5) 14 (9–24.5) .052
Intensive care unit admission 19 (16.7) 10 (16.4) 9 (17) .933
Treatment
 Antibiotic and drainage 98 (86) 52 (85.2) 46 (86.8) .813
 Antibiotic and operation 1 (0.9) 1 (1.6) 0 1.000
 Only antibiotic 15 (13.2) 8 (13.1) 7 (13.2) .988

Data are presented as n (%) of patients unless stated otherwise.

aCryptogenic KPLA was defined as those cases without obvious extrahepatic source of infection; biliary KPLA was defined when the clinical features of cholecystitis/cholangitis or extrahepatic biliary. Ductal abnormalities were identified by image studies.

bOne patient underwent colonoscopy, revealing an abscess located in the caudate lobe.

cDefined as >2 abscesses on imaging.

Among the 13 patients diagnosed with adenocarcinoma, 2 did not undergo surgery due to the very early stage of cancer, while 11 did. Finally, 11 patients achieved disease-free survival. A 58-year-old female underwent surgery for cancer and showed no recurrence during the follow-up period; however, she died of pneumonia 1 year later. Another 60-year-old male received chemotherapy after surgery for colorectal cancer but died of septic shock 3 years later. Among the 48 patients who underwent polypectomy for adenoma, 2 were later diagnosed with colorectal cancer during the 1–3 year follow-up period. Both patients underwent surgery for colorectal cancer and have survived disease-free to date. Other patients did not have a diagnosis of colorectal cancer during the 1–6 years of follow-up period. Among the 53 patients without colorectal adenoma or adenocarcinoma, 1 died of pneumonia 1 year following diagnosis of KPLA. Eight patients underwent follow-up colonoscopy within 1–9 years following KPLA, and only 2 were found to have tubular adenomas.

The analysis of the risk factors for colorectal adenoma or adenocarcinoma in patients is shown in Table 3. In the multivariate analysis, age ≥ 50 years (OR = 5.728, 95% CI = 2.045–16.04; P = .001) was the only independent predictor of colorectal adenoma or adenocarcinoma in patients with KPLA.

Table 3.

Risk Factors for Colorectal Adenoma or Adenocarcinoma in Patients With KPLA

Variables Univariate Analysis Multivariate Analysis
OR (95% CI) P value OR (95% CI) P value
Age > 50 5.556 (2.025–15.242) .001 5.728 (2.045–16.04) .001
Gender 0.452 (0.205–0.999) .005 0.513 (0.22–1.2) .124

CI, confidence interval; OR, odds ratio.

Comparison of Clinical Characteristics of Patients With KPLA With or Without Colorectal Adenocarcinoma

We compared the clinical characteristics of patients with and without adenocarcinoma (Table 4). Patients with adenocarcinoma had a higher proportion of those aged ≥ 50 years. The analysis of the risk factors for patients with colorectal adenocarcinoma is shown in Table 5. In multivariate analysis, both male sex (P = .058) and bilateral lobe involvement (P = .059) were marginally significantly associated with colorectal adenocarcinoma in patients with KPLA.

Table 4.

Comparison of Clinical Characteristics of Patients With KPLA With or Without Colorectal Adenocarcinoma

Characteristics Total
n = 114
Adenocarcinoma
n = 13 (11.4)
Not Adenocarcinoma
n = 101 (88.6)
P Value
Male, n (%) 73 (64) 5 (38.5) 68 (67.3) .063
Age, years (medium IQR) 60.5 (15.8–69) 68 (59–74.5) 60 (49–68) .062
Age ≥50 years 88 (77.2) 13 (100) 75 (74.3) .038
Body mass index, kg/m2 (medium IQR) 25.3 (22.6–28) 24.1 (21.7–26.2) 25.5 (22.7–28.4) .182
Obesity (body mass index ≥24) 71 (65.7) 7 (53.8) 64 (67.4) .362
Comorbidity, n (%)
 Diabetes mellitus 44 (38.6) 7 (53.8) 37 (36.6) .23
 Cancer 8 (7) 2 (15.4) 6 (5.9) .226
 Liver cirrhosis 1 (0.9) 0 1 (1) 1.000
 Congestive heart failure 4 (3.5) 0 4 (4) 1.000
 Chronic obstructive pulmonary disease 2 (1.8) 1 (7.7) 1 (1) .216
 Chronic kidney disease (eGFR < 60) 8 (7) 2 (15.4) 6 (5.9) .226
 Cerebrovascular accident 1 (0.9) 1 (7.7) 0 .114
Origin of K. pneumoniae liver abscessa
 Cryptogenic 105 (92.1) 12 (92.3) 93 (92.1) 1.000
 Biliary 9 (7.9) 1 (7.7) 8 (7.9) 1.000
Abscess locationb
 Right lobes 82 (71.9) 8 (61.5) 74 (73.3) .512
 Left lobes 22 (19.3) 1 (7.7) 21 (20.8) .457
 Both lobes 9 (7.9) 3 (23.1) 6 (5.9) .066
Abscess size (medium IQR) 5.1 (3.5–7.3) 5 (4.7–6.4) 5.2 (3.4–7.5) .915
Abscess size > 5cm 59 (51.8) 6 (46.2) 53 (52.5) .668
Gas forming 6 (5.3) 1 (7.7) 5 (5) .525
Multiple liver abscessc 12 (10.5) 2 (15.4) 10 (9.9) .626
Metastatic lesion 6 (5.3) 2 (15.4) 4 (4) .139
Bacteremia 54 (47.4) 5 (38.5) 49 (48.5) .494
Length of stay (medium IQR) 17 (10–28.3) 22 (14.5–39.5) 17 (10–27.5) .111
Intensive care unit admission 19 (16.7) 2 (15.4) 17 (16.8) 1.000
Treatment
 Antibiotic and drainage 98 (86) 10 (76.9) 88 (87.1) .39
 Antibiotic and operation 1 (0.9) 1 (7.7) 0 .114
 Only antibiotic 15 (13.2) 2 (15.4) 13 (12.9) .68

Data are presented as n (%) of patients unless stated otherwise.

aCryptogenic KPLA was defined as those cases without obvious extrahepatic source of infection; biliary KPLA was defined when the clinical features of cholecystitis/cholangitis or extrahepatic biliary. Ductal abnormalities were identified by image studies.

bOne patient underwent colonoscopy, revealing an abscess located in the caudate lobe.

cDefined as >2 abscesses on imaging.

Table 5.

Risk Factors for Colon Cancer (Adenocarcinoma) in Patients With KPLA

Variables Univariate Analysis Multivariate Analysis (Forward Selection)
OR (95% CI) P value OR (95% CI) P value
Gender 0.303 (0.092–0.999) .05 0.309 (0.092–1.042) .058
Both lobes 4.75 (1.027–21.968) .046 4.75 (1.027–21.968) .059
Age 1.040 (0.994–1.089) .088

DISCUSSION

Among the 114 patients who underwent colonoscopy within 6 months of KPLA diagnosis, 48 had colorectal adenoma and 13 had colorectal adenocarcinoma. Age ≥ 50 years was the only independent predictor for colorectal adenoma/adenocarcinoma. Our findings indicate that underlying colorectal neoplasia is prevalent among patients with KPLA, underscoring the importance of routine colonoscopy following a KPLA diagnosis.

Previous studies have reported an association between liver abscesses and subsequent colorectal cancer and revealed that patients with liver abscesses had an increased risk of colorectal cancer during the long-term follow-up period [17–19]. A population-based study in Taiwan reported that patients with cryptogenic liver abscesses between 2000 and 2004 had a significantly higher incidence of colorectal cancer than the general population (5.5% vs 1.8%) during a 5-year follow-up period [17]. Kao et al [18] conducted another nationwide cohort study in Taiwan between 2000 and 2007 and found that 40 out of 1257 patients (3.2%) developed colorectal cancer during the follow-up period, but the follow-up period was not specified. Huang et al [19] also conducted a retrospective cohort study at a medical center in northern Taiwan, involving 1194 patients diagnosed with KPLA between 2000 and 2009. Over an 11-year follow-up period, 42 patients with KPLA (3.4%) were diagnosed with colorectal cancer. Most liver abscesses in Taiwan are caused by K. pneumoniae [20–23], and the aforementioned 3 Taiwanese studies showed an increased risk of colorectal cancer in patients with KPLA during extended follow-up periods.

Most liver abscesses in Korea are also caused by K. pneumoniae [24]. Koo et al retrospectively analyzed 163 patients with cryptogenic liver abscesses at a single institute in Korea between 2001 and 2010; 121 patients underwent colonoscopy. The authors found a colorectal cancer prevalence of 7.4% (12/163); this study was also limited by the unknown timing of colonoscopy after liver abscess in 121 patients [12]. Jeong et al reported a colorectal cancer detection rate of 16.2% (6/37) among patients with liver abscesses diagnosed between 2003 and 2010 who underwent colonoscopy within 6 weeks of PLA diagnosis. To the best of our knowledge, this is the only study focusing on occult colorectal cancer for the diagnosis of KPLA. However, the limited number (37 cases) of colonoscopy cases restricts the implications of these results [13]. In addition, a United States retrospective cohort study followed 8286 patients with PLA and 23 201 matched controls for up to 10 years and diagnosed colorectal cancer in a significantly higher proportion of PLA patients than controls (1.9% vs 0.8%; P < .001). However, K. pneumoniae was identified as the etiology in 20% of these cases. Notably, this study also suggested that undiagnosed colorectal cancer is a likely cause of cryptogenic PLA [25]. These aforementioned studies usually focused on the incidence of colorectal cancer during long-term follow-up in patients with liver abscesses and do not indicate whether colorectal cancer was already present at the time of liver abscess diagnosis. Meanwhile, in our study, colonoscopy was performed within 6 months of KPLA diagnosis, and our findings, which identified colorectal cancer in 11.4% of patients, emphasize the significant role of colonoscopic screening in the diagnosis of KPLA.

The adenoma–carcinoma sequence theory indicates that colorectal cancer develops through stepwise progression from normal to dysplastic epithelium to carcinoma [26]. The literature suggests that the removal of adenomas during colonoscopy can reduce colorectal cancer mortality by as much as 53% [27]. A high detection rate of colorectal adenoma in the diagnosis of KPLA has not yet been reported; only a few case reports from Taiwan and Korea have addressed this finding [28–32]. In our study of 48 patients who underwent polypectomy for adenoma, only 2 were diagnosed with colorectal cancer during the follow-up period. All 48 patients had disease-free survival. Among the 13 patients with colorectal cancer, 11 had disease-free survival. In contrast to previous studies, our study period spans 2011–2024, which is representative of the real-world situation in the current era. No professional guidelines recommend colorectal cancer screening for patients diagnosed with KPLA. Our findings underscore the high prevalence of occult colorectal neoplasia in patients with KPLA, and we strongly recommend routine colonoscopic evaluations in these patients.

In the current study, we had provided microbiological information of K. pneumoniae strains and demonstrated most of them were hypervirulent strains. However, diagnostic capacity may vary across different regions, and molecular diagnostics are not readily available in resource-constrained setting. Hypervirulent K. pneumoniae strains are frequently associated with a hypermucoviscous phenotype, and the string test may serve as a practical screening method to identify hypervirulent strains [33]. Our study had some limitations. First, this was a retrospective analysis conducted at a single tertiary referral center, which may limit the generalizability of the findings. Second, the number of patients who underwent colonoscopy following KPLA diagnosis was limited; however, our case numbers are the largest in the literature. Third, although our findings strongly support the high detection rate of colorectal neoplasia in patients with KPLA, they may be limited by a lack of comparison with patients without KPLA.

In conclusion, our study demonstrated that patients with KPLA have a high detection rate of underlying colorectal neoplasia, including both adenomas and adenocarcinomas. Age ≥ 50 years is a risk factor for adenoma and cancer. Our findings emphasize the importance of routine colonoscopy in patients with KPLA, particularly in those aged ≥ 50 years.

Notes

Acknowledgements. The preliminary data of this study were presenting ID week 2024 as a paper poster. We sincerely thank Medical Science and Technology Building of the Taipei Veterans General Hospital for providing experimental space and facilities.

Author Contributions. T. E. L. performed the data collection and analysis and wrote the original draft of the manuscript. C. C. contributed to study design and data analysis. Y. T. L. contributed to the study design, data collection, data analysis, and manuscript revision. S. H. C. contributed to the laboratory experiments. S. Y. L., Y. C. H., and W. C. revised the manuscript. All authors have reviewed and approved the final manuscript.

Ethical Approval. Ethical approval was obtained from the Institutional Review Board of the Taipei Veterans General Hospital. The requirement for informed consent was waived due to the retrospective nature of the study.

Data availability. Due to the sensitive nature of the questions asked in this study, survey respondents were assured that the raw data would remain confidential and would not be shared.

Financial support. This work was supported by grants from the National Science and Technology Council (NSTC 112-2314-B-A49-029 and NSTC 114-2314-B-A49-079-MY3) of Taiwan, the Taipei Veterans General Hospital (V112C-102, V113C-073, V114C-047, V115C-170 and V115B-001), the Szu-Yuan Research Foundation of Internal Medicine, and Y.L. Lin Hung Tai Education Foundation. The funders had no role in the study design, data collection, and interpretation, or decision to submit the work for publication.

Contributor Information

Tsen-En Liao, Institute of Emergency and Critical Care Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Center for Infection Control, Taipei Veterans General Hospital, Taipei, Taiwan.

Chien Chuang, Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.

Szu-Yu Liu, Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.

Yu-Chien Ho, Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Department of Medicine, Kinmen Hospital, Ministry of Health and Welfare, Kinmen, Taiwan.

Wan Chin, Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.

Sheng-Hua Chou, Institute of Emergency and Critical Care Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Center for Infection Control, Taipei Veterans General Hospital, Taipei, Taiwan.

Yi-Tsung Lin, Institute of Emergency and Critical Care Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Center for Infection Control, Taipei Veterans General Hospital, Taipei, Taiwan; Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.

References

  • 1. Chen  YC, Lin  CH, Chang  SN, Shi  ZY. Epidemiology and clinical outcome of pyogenic liver abscess: an analysis from the national health insurance research database of Taiwan, 2000-2011. J Microbiol Immunol Infect  2016; 49:646–53. [DOI] [PubMed] [Google Scholar]
  • 2. Lin  YT, Liu  CJ, Yeh  YC, Chen  TJ, Fung  CP. Ampicillin and amoxicillin use and the risk of Klebsiella pneumoniae liver abscess in Taiwan. J Infect Dis  2013; 208:211–7. [DOI] [PubMed] [Google Scholar]
  • 3. Yeh  KM, Kurup  A, Siu  LK, et al.  Capsular serotype K1 or K2, rather than magA and rmpA, is a major virulence determinant for Klebsiella pneumoniae liver abscess in Singapore and Taiwan. J Clin Microbiol  2007; 45:466–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Siu  LK, Yeh  KM, Lin  JC, Fung  CP, Chang  FY. Klebsiella pneumoniae liver abscess: a new invasive syndrome. Lancet Infect Dis  2012; 12:881–7. [DOI] [PubMed] [Google Scholar]
  • 5. Fung  CP, Lin  YT, Lin  JC, et al.  Klebsiella pneumoniae in gastrointestinal tract and pyogenic liver abscess. Emerg Infect Dis  2012; 18:1322–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Tu  YC, Lu  MC, Chiang  MK, et al.  Genetic requirements for Klebsiella pneumoniae-induced liver abscess in an oral infection model. Infect Immun  2009; 77:2657–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Lin  YT, Siu  LK, Lin  JC, et al.  Seroepidemiology of Klebsiella pneumoniae colonizing the intestinal tract of healthy Chinese and overseas Chinese adults in Asian countries. BMC Microbiol  2012; 12:13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Chung  DR, Lee  H, Park  MH, et al.  Fecal carriage of serotype K1 Klebsiella pneumoniae ST23 strains closely related to liver abscess isolates in Koreans living in Korea. Eur J Clin Microbiol Infect Dis  2012; 31:481–6. [DOI] [PubMed] [Google Scholar]
  • 9. Xi  Y, Xu  P. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol  2021; 14:101174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Druliner  BR, Rashtak  S, Ruan  X, et al.  Colorectal cancer with residual polyp of origin: a model of malignant transformation. Transl Oncol  2016; 9:280–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Cohen  JL, Martin  FM, Rossi  RL, Schoetz  DJ  Jr. Liver abscess. The need for complete gastrointestinal evaluation. Arch Surg  1989; 124:561–4. [DOI] [PubMed] [Google Scholar]
  • 12. Koo  HC, Kim  YS, Kim  SG, et al.  Should colonoscopy be performed in patients with cryptogenic liver abscess?  Clin Res Hepatol Gastroenterol  2013; 37:86–92. [DOI] [PubMed] [Google Scholar]
  • 13. Jeong  SW, Jang  JY, Lee  TH, et al.  Cryptogenic pyogenic liver abscess as the herald of colon cancer. J Gastroenterol Hepatol  2012; 27:248–55. [DOI] [PubMed] [Google Scholar]
  • 14. Chuang  C, Fan  WC, Lin  YT, Wang  FD. The emergence of Klebsiella pneumoniae liver abscess in non-diabetic patients and the distribution of capsular types. Gut Pathog  2016; 8:46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Magiorakos  AP, Srinivasan  A, Carey  RB, et al.  Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect  2012; 18:268–81. [DOI] [PubMed] [Google Scholar]
  • 16. Turton  JF, Payne  Z, Coward  A, et al.  Virulence genes in isolates of Klebsiella pneumoniae from the UK during 2016, including among carbapenemase gene-positive hypervirulent K1-ST23 and ‘non-hypervirulent’ types ST147, ST15 and ST383. J Med Microbiol  2018; 67:118–28. [DOI] [PubMed] [Google Scholar]
  • 17. Lai  HC, Lin  HC. Cryptogenic pyogenic liver abscess as a sign of colorectal cancer: a population-based 5-year follow-up study. Liver Int  2010; 30:1387–93. [DOI] [PubMed] [Google Scholar]
  • 18. Kao  WY, Hwang  CY, Chang  YT, et al.  Cancer risk in patients with pyogenic liver abscess: a nationwide cohort study. Aliment Pharmacol Ther  2012; 36:467–76. [DOI] [PubMed] [Google Scholar]
  • 19. Huang  WK, Chang  JC, See  LC, et al.  Higher rate of colorectal cancer among patients with pyogenic liver abscess with Klebsiella pneumoniae than those without: an 11-year follow-up study. Colorectal Dis  2012; 14:e794–801. [DOI] [PubMed] [Google Scholar]
  • 20. Wu  PF, Chang  YY, Lin  YT, Wang  FD, Chan  YJ, Fung  CP. Clinical characteristics and economic consequence of Klebsiella pneumoniae liver abscess in Taiwan. J Microbiol Immunol Infect  2015; 48:190–7. [DOI] [PubMed] [Google Scholar]
  • 21. Lin  YT, Wang  FD, Wu  PF, Fung  CP. Klebsiella pneumoniae liver abscess in diabetic patients: association of glycemic control with the clinical characteristics. BMC Infect Dis  2013; 13:56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Lin  YT, Cheng  YH, Chuang  C, et al.  Molecular and clinical characterization of multidrug-resistant and hypervirulent Klebsiella pneumoniae strains from liver abscess in Taiwan. Antimicrob Agents Chemother  2020; 64:e00174-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Chuang  C, Chou  SH, Wang  FD, Huang  YH, Tsai  TH, Lin  YT. Fluoroquinolones as an alternative treatment for Klebsiella pneumoniae liver abscess and impact on hospital length of stay. Int J Antimicrob Agents  2020; 56:106120. [DOI] [PubMed] [Google Scholar]
  • 24. Chung  D, Lee  S, Lee  H, et al.  Emerging invasive liver abscess caused by K1 serotype Klebsiella pneumoniae in Korea. J Infect  2007; 54:578–83. [DOI] [PubMed] [Google Scholar]
  • 25. Suzuki  H, Kidder  I, Tanaka  T, Goto  M. Incidence of colorectal cancer in patients diagnosed with pyogenic liver abscess. JAMA Netw Open  2023; 6:e2348218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Leslie  A, Carey  F, Pratt  N, Steele  R. The colorectal adenoma–carcinoma sequence. Br J Surg  2002; 89:845–60. [DOI] [PubMed] [Google Scholar]
  • 27. Zauber  AG, Winawer  SJ, O'Brien  MJ, et al.  Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med  2012; 366:687–96. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Lai  HC, Chan  CY, Peng  CY, Chen  CB, Huang  WH. Pyogenic liver abscess associated with large colonic tubulovillous adenoma. World J Gastroenterol  2006; 12:990–2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Hsu  WH, Yu  FJ, Chuang  CH, Chen  CF, Lee  CT, Lu  CY. Occult colon cancer in a patient with diabetes and recurrent Klebsiella pneumoniae liver abscess. Kaohsiung J Med Sci  2009; 25:98–103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Kang  MK, Kwon  HJ, Kim  MC. Gastric cancer and adenomatous colorectal polyp concomitant with pyogenic liver abscess and bacteremia. Yeungnam Univ J Med  2020; 37:246–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Kim  HY, Kim  CW, Kim  DR, et al.  Recurrent pyogenic liver abscess as a presenting manifestation of colorectal cancer. Korean J Intern Med  2017; 32:174–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Park  JG, Suh  JI, Kim  YU. Gastric heterotopia of colon found cancer workup in liver abscess: a case report. World J Clin Cases  2022; 10:5012–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Shon  AS, Bajwa  RP, Russo  TA. Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed. Virulence  2013; 4:107–18. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Open Forum Infectious Diseases are provided here courtesy of Oxford University Press

RESOURCES